Vaccination Strategies for Mastitis

Veterinary Clinics of North America - Food Animal Practice

Volumn 28, Issue 2, 2012, Pages 257-270

  Erskine, R J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Dairy; Mastitis; Vaccination

Indexed keywords

BACTERIAL VACCINE;

ANIMAL; ANIMAL DISEASE; BOVINE MASTITIS; CATTLE; DAIRYING; FEMALE; IMMUNOLOGY; LACTATION; METHODOLOGY; REVIEW; VACCINATION;

ANIMALS; BACTERIAL VACCINES; CATTLE; DAIRYING; FEMALE; LACTATION; MASTITIS, BOVINE; VACCINATION;

EID: 84861778157     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2012.03.002     Document Type: Review

References (62)

1. Rainard P., Riollet C. Innate immunity of the bovine mammary gland. Vet Res 2006, 37:369-400.
2. Sordillo L.M., Streicher K.L. Mammary gland immunity and mastitis susceptibility. J Mamm Gland Biol Neoplasia 2002, 7:135-146.
3. Kehrli M.E., Harp J.A. Immunity in the mammary gland. Vet Clin North Am Food Anim Pract 2001, 17:495-516.
4. Innate immunity. Janeway's immunobiology 2008, 53-60. Garland Science, New York. 7th edition. K. Murphy, P. Travers, M. Walport (Eds.).
5. Netea M.G., Van Der Graaf C., Van Der Meer J.W., et al. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol 2004, 75:749-755.
6. Park Y.H., Fox L.K., Hamilton M.J., et al. Suppression of proliferative responses of BoCD4C T lymphocytes by activated BoCD8C T lymphocytes in the mammary gland of cows with Staphylococcus aureus mastitis. Vet Immunol Immunopathol 2003, 36:137-151.
7. Shafer-Weaver K.A., Sordillo L.M. Bovine CD8C suppressor lymphocytes alter immune responsiveness during the postpartum period. Vet Immunol Immunopathol 1997, 56:53-64.
8. Smith K.L., Schanbacher F.L. Lactoferrin as a factor of resistance to infection of the bovine mammary gland. J Am Vet Med Assoc 1977, 170:1224-1227.
9. Mullan N.A., Carter E.A., Nguyen K.A. Phagocytic and bactericidal properties of bovine macrophages from non-lactating mammary glands. Res Vet Sci 1985, 38:160-166.
10. Preisler M.T., Weber P.S., Tempelman R.J., et al. Glucocorticoid receptor down-regulation in neutrophils of periparturient cows. Am J Vet Res 2000, 61:14-19.
11. Kehrli M.E., Nonnecke B.J., Roth J.A. Alterations in bovine neutrophil function during the periparturient period. Am J Vet Res 1989, 50:207-214.
12. Waller K.P. Mammary gland immunology around parturition. Influence of stress, nutrition and genetics. Adv Exp Med Biol 2000, 480:231-245.
13. Cai T.Q., Weston P.G., Lund L.A., et al. Association between neutrophil functions and periparturient disorders in cows. Am J Vet Res 1994, 55:934-943.
14. Contreras G.A., Sordillo L.M. Lipid mobilization and inflammatory responses during the transition period of dairy cows. Comp Immunol Microbiol Infect Dis 2011, 34:281-289.
15. Rauff Y., Moore D.A., Sischo W.M. Evaluation of the results of a survey of dairy producers on dairy herd biosecurity and vaccination against bovine viral diarrhea. J Am Vet Med Assoc 1996, 209:1618-1622.
16. Cullor J.S. The Escherichia coli J5 vaccine: investigating a new tool to combat coliform mastitis. Vet Med 1991, 86:836-844.
17. Tyler J.W., Cullor J.S., Spier S.J. Immunity targeting common core antigens of gram-negative bacteria. J Intern Med 1990, 4:17-25.
18. Tyler J.W., Cullor J.S., Dellinger J.D. Cross reactive affinity purification of immunoglobulin recognizing common gram-negative bacterial core antigens. J Immunol Methods 1990, 129:221-226.
19. Tomita G.M., Todhunter D.A., Hogan J.S., et al. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G. J Dairy Sci 1995, 78:2745-2752.
20. Chaiyotwittayakun A., Burton J.L., Weber P.S.D., et al. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria. J Dairy Sci 2004, 87:3375-3385.
21. Tyler J.W., Cullor J.S., Osburn B.I., et al. Relationship between serologic recognition of Escherichia coli O111: B4 (J5) and clinical coliform mastitis in cattle. Am J Vet Res 1988, 49:1950-1954.
22. Gonzalez R.N., Cullor J.S., Jasper D.E., et al. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res 1989, 53:301-305.
23. Hogan J.S., Smith K.L., Todhunter D.A., et al. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J Dairy Sci 1992, 75:78-84.
24. Hogan J.S., Weiss W.P., Todhunter D.A., et al. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial. J Dairy Sci 1992, 75:415-422.
25. Tomita G.M., Ray C.H., Nickerson S.C., et al. A comparison of two commercially available Escherichia coli J5 vaccines against E. coli intramammary challenge. J Dairy Sci 2000, 83:2276-2281.
26. Wenz J.R., Barrington G.M., Garry F.B., et al. Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc 2001, 219:976-981.
27. Wilson D.J., Grohn Y.T., Bennett G.J., et al. Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis. J Dairy Sci 2007, 90:4282-4288.
28. Wilson D.J., Grohn Y.T., Bennett G.J., et al. Milk production change following clinical mastitis and reproductive performance compared among J5 vaccinated and control dairy cattle. J Dairy Sci 2008, 91:3869-3879.
29. Mallard B.A., Wagter L.C., Ireland M.J., et al. Effects of growth hormone, insulin-like growth factor I, and cortisol on periparturient antibody response profiles of dairy cattle. Vet Immunol Immunopathol 1997, 60:61-76.
30. Wilson D.J., Mallard B.A., Burton J.L., et al. Association of Escherichia coli J5-specific serum antibody responses with clinical mastitis outcome for J5 vaccinate and control dairy cattle. Clin Vaccine Immun 2009, 16:209-217.
31. Erskine R.J., VanDyk E.J., Bartlett P.C., et al. Effect of hyperimmunization with an Escherichia coli J5 bacterin in adult lactating dairy cows. J Am Vet Med Assoc 2007, 231:1092-1097.
32. Erskine R.J., Brockett A.R., Beeching N.D., et al. Effect of changes in number of doses and anatomic location for administration of an Escherichia coli bacterin on serum IgG1 and IgG2 concentrations in dairy cows. Am J Vet Res 2010, 71:120-124.
33. McClure A.M., Christopher E.E., Wolff W.A., et al. Effect of Re-17 mutant Salmonella typhimurium bacterin toxoid on clinical coliform mastitis. J Dairy Sci 1994, 77:2272-2280.
34. DeGraves F.J., Fetrow J. Partial budget analysis of vaccinating dairy cattle against coliform mastitis with an Escherichia coli J5 vaccine. J Am Vet Med Assoc 1991, 199:451-455.
35. Almeida R.A., Dogan B., Klaessing S., et al. Intracellular fate of strains of Escherichia coli isolated from dairy cows with acute or chronic mastitis. Vet Res Commun 2011, 35:89-101.
36. Yancey R.J., Dominowski P.J., Erskine R.J., et al. Evaluations of J5 bacterins in cows with novel immunomodulating formulations (abstract). Fifth International Dairy Federation Mastitis Conference; Christchurch (New Zealand) 2010.
37. Musser J.M., Anderson K.L. Effect of vaccination with an Escherichia coli bacterin-toxoid on milk production in dairy cattle. J Am Vet Med Assoc 1996, 209:1291-1293.
38. Borm A.A., Fox L.K., Leslie K.E., et al. Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J Dairy Sci 2006, 89:2090-2098.
39. Petzl W., Zerbe H., Günther J., et al. Escherichia coli, but not Staphylococcus aureus triggers an early increased expression of factors contributing to the innate immune defense in the udder of the cow. Vet Res 2008, 39:18-26.
40. Middleton J.R., Luby C.D., Viera L., et al. Influence of Staphylococcus aureus intramammary infection on serum copper, zinc, and iron concentrations. J Dairy Sci 2004, 87:976-979.
41. Sears P.M., Fettinger M., Marsh-Salin J. Isolation of L-form variants after antibiotic treatment in Staphylococcus aureus bovine mastitis. J Am Vet Med Assoc 1987, 191:681-684.
42. Sears P.M., Smith B.S., English P.B., et al. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. J Dairy Sci 1990, 73:2785-2789.
43. Nickerson S.C., Owens W.E., Tomita G.M., et al. Vaccinating dairy heifers with a Staphylococcus aureus bacterin reduces mastitis at calving. Large Anim Pract 1999, 20:16-28.
44. Middleton J.R., Ma J., Rinehart C.L., et al. Efficacy of different Lysigin formulations in the prevention of Staphylococcus aureus intramammary infection in dairy heifers. J Dairy Res 2006, 73:10-19.
45. Luby C.D., Middleton J.R., Ma J., et al. Characterization of the antibody isotype response in serum and milk of heifers vaccinated with a Staphylococcus aureus bacterin (Lysigin). J Dairy Res 2007, 74:239-246.
46. Middleton J.R., Luby C.D., Adams D.S. Efficacy of vaccination against staphylococcal mastitis: a review and new data. Vet Microsc 2009, 134:192-198.
47. Leitner G., Lubashevsky E., Glickman A., et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials. Vet Immun Immunopathol 2003, 93:31-38.
48. Leitner G., Yadlin N., Lubashevsky E., et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trials. Vet Immun Immunopathol 2003, 93:153-158.
49. Leitner G., Krifucks O., Madanahally D.K., et al. Vaccine development for the prevention of staphylococcal mastitis in dairy cows. Vet Immun Immunopathol 2011, 142:25-35.
50. Prenafeta A., March R., Foix A., et al. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-imbedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis. Vet Immun Immunopathol 2010, 134:208-217.
51. Jiminez L.M., Romero C. Efficacy of vaccination on mastitis epidemiology: field study. Proceedings of the 50th Annual National Mastitis Council Meeting 2011, 171-172. National Mastitis Council, Verona (WI).
52. Noguera M., March R., Guix R., et al. Evaluation of the efficacy of a new vaccine against bovine mastitis caused by CNS field trial results. Proceedings of the 50th Annual National Mastitis Council Meeting 2011, 187-188. National Mastitis Council, Verona (WI).
53. Luby C.D., Middleton J.R. Efficacy of vaccination and antibiotic therapy against Staphylococcus aureus mastitis in dairy cattle. Vet Rec 2005, 157:89-90.
54. Smith G.W., Lyman R.L., Anderson K.L. Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle. J Am Vet Med Assoc 2006, 228:422-425.
55. Jayarao B.M., Gillispie B.E., Lewis M.J., et al. Epidemiology of Streptococcus uberis intramammary infections in a dairy herd. J Vet Med 1999, 46:442.
56. Tamilselvam B., Almeida R.A., Dunlap J.R., et al. Streptococcus uberis internalizes and persists in bovine mammary epithelial cells. Microb Pathol 2006, 40:279-285.
57. Zadoks R.N., Gillespie B.E., Barkema H.W., et al. Clinical, epidemiological and molecular characteristics of Streptococcus uberis infections in dairy herds. Epidemiol Infect 2003, 130:335-349.
58. Finch J.M., Winter A., Walton A.W., et al. Further studies on the efficacy of a live vaccine against mastitis caused by Streptococcus uberis. Vaccine 1997, 15:1138-1143.
59. Leigh J.A. Vaccines against bovine mastitis due to Streptococcus uberis current status and future prospects. Adv Exp Med Biol 2000, 480:307-311.
60. Almeida R.A., Luther D.A., Park H.M., et al. Identification, isolation, and partial characterization of a novel Streptococcus uberis adhesion molecule (SUAM). Vet Microsc 2006, 115:183-191.
61. Luther D.A., Almeida R.A., Oliver S.P. Elucidation of the DNA sequence of Streptococcus uberis adhesion molecule (SUA) and detection of SUA in strains of Streptococcus uberis isolated from geographically diverse locations. Vet Microsc 2008, 128:304-312.
62. Prado M.E., Almeida R.A., Ozen C., et al. Vaccination of dairy cows with recombinant Streptococcus uberis adhesion molecule induces antibodies that reduce adherence to and internalization of S. uberis into bovine mammary epithelial cells. Vet Immun Immunopathol 2011, 35:145-156.